title: Omalizumab in chronic spontaneous urticaria: patient-tailored tapering or planned discontinuation?
authors.affiliation: Department of Internal Medicine, Allergy Unit, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy. Electronic address: c.tontini@live.com.
authors.forename: Chiara
authors.initials: C
authors.lastname: Tontini
authors.affiliation: Department of Internal Medicine, Allergy Unit, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy.
authors.forename: Lucia
authors.initials: L
authors.lastname: Marinangeli
authors.affiliation: Department of Internal Medicine, Allergy Unit, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy.
authors.forename: Miriam
authors.initials: M
authors.lastname: Cognigni
authors.affiliation: Department of Internal Medicine, Allergy Unit, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy.
authors.forename: Maria Beatrice
authors.initials: MB
authors.lastname: Bilò
authors.affiliation: Department of Internal Medicine, Allergy Unit, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy.
authors.forename: Leonardo
authors.initials: L
authors.lastname: Antonicelli
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002908:Chronic Disease; D003888:Desensitization, Immunologic; D004334:Drug Administration Schedule; D054796:Drug Dosage Calculations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab; D017410:Practice Guidelines as Topic; D057285:Precision Medicine; D011241:Prednisone / Q000627:therapeutic use; D012720:Severity of Illness Index; D014581:Urticaria / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology
chemical_list: D000305:Adrenal Cortex Hormones; D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D011241:Prednisone